活动能力与多病共存对老年男性住院及急性后期医疗服务利用的影响
本研究基于MrOS研究第7年1701名老年男性(平均年龄79.3岁)的前瞻性数据,链接Medicare索赔,发现活动能力下降与多病负担独立预测住院及急性后期照护机构使用天数,且两者并存时联合效应显著。
要点
- 活动能力差与多病高负担独立关联住院和急性后期照护使用增加。
- 活动能力差且多病高负担者年均总机构天数达5.50天,约为活动能力好且无多病者的九倍。
- 临床决策与照护规划需考虑活动能力与多病共存的联合效应。
核心结论
- 在老年男性中,活动能力受限与多病共存是住院及急性后期照护利用的独立预测因素。
- 活动能力差与多病高负担并存时,年均总机构天数显著增加,联合效应明显。
研究设计与样本
- 前瞻性研究,纳入MrOS研究第7年(2007-2008)的1701名老年男性,平均年龄79.3岁,链接Medicare索赔数据。
- 第7年通过习惯性步速评估活动能力,分为差、中等、好三类;用Elixhauser算法量化多病,分为无、轻中度、高三类。
- 追踪第7年后12个月内的住院和急性后期照护机构停留情况。
主要发现
- 调整彼此及传统指标后,活动能力下降和多病负担增加均独立关联更高的住院及急性后期照护机构使用风险。
- 调整后年均总机构天数:活动能力好者1.13天(95%CI 0.74-1.40),差者2.43天(95%CI 1.17-3.84)。
- 调整后年均总机构天数:无多病者0.67天(95%CI 0.38-0.91),多病高负担者2.70天(95%CI 1.58-3.77)。
- 活动能力差且多病高负担者年均总机构天数5.50天(95%CI 2.78-10.87),活动能力好且无多病者0.59天(95%CI 0.37-0.95),前者约为后者的九倍。
临床怎么用
- 对老年男性进行活动能力(如步速)和多病负担评估,有助于识别住院及急性后期照护高利用风险者。
- 在临床决策和照护规划中,应同时考虑活动能力受限与多病共存的联合影响。
局限性
- 研究仅纳入老年男性,结果推广至女性需谨慎。
- 活动能力仅通过步速评估,多病使用Elixhauser算法基于索赔数据,可能存在测量偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study examines effects of mobility and multimorbidity on hospitalization and inpatient and postacute care (PAC) facility days among older men. METHODS: Prospective study of 1,701 men (mean age 79.3 years) participating in Osteoporotic Fractures in Men (MrOS) Study Year 7 (Y7) examination (2007-2008) linked with their Medicare claims. At Y7, mobility ascertained by usual gait speed and categorized as poor, intermediate, or good. Multimorbidity quantified by applying Elixhauser algorithm to inpatient and outpatient claims and categorized as none, mild-moderate, or high. Hospitalizations and PAC facility stays ascertained during 12 months following Y7. RESULTS: Reduced mobility and greater multimorbidity burden were independently associated with a higher risk of inpatient and PAC facility utilization, after accounting for each other and traditional indicators. Adjusted mean total facility days per year were 1.13 (95% confidence interval [CI] = 0.74-1.40) among men with good mobility increasing to 2.43 (95% CI = 1.17-3.84) among men with poor mobility, and 0.67 (95% CI = 0.38-0.91) among men without multimorbidity increasing to 2.70 (95% CI = 1.58-3.77) among men with high multimorbidity. Men with poor mobility and high multimorbidity had a ninefold increase in mean total facility days per year (5.50, 95% CI = 2.78-10.87) compared with men with good mobility without multimorbidity (0.59, 95% CI = 0.37-0.95). CONCLUSIONS: Among older men, mobility limitations and multimorbidity were independent predictors of higher inpatient and PAC utilization after considering each other and conventional predictors. Marked combined effects of reduced mobility and multimorbidity burden may be important to consider in clinical decision-making and planning health care delivery strategies for the growing aged population.
引用
- Ensrud KE, Lui LY, Langsetmo L, et al. Effects of Mobility and Multimorbidity on Inpatient and Postacute Health Care Utilization. J Gerontol A Biol Sci Med Sci. 2018. PMID: 28645202. doi:10.1093/gerona/glx128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。